| 2A1T | R:209-333 | STRUCTURE OF THE HUMAN MCAD:ETF E165BETAA COMPLEX |
| 2A1U | A:208-333 | CRYSTAL STRUCTURE OF THE HUMAN ETF E165BETAA MUTANT |
| 3GLS | A:; B:; C:; D:; E:; F: | CRYSTAL STRUCTURE OF HUMAN SIRT3 |
| 4BN4 | A: | STRUCTURE OF HUMAN SIRT3 IN COMPLEX WITH ADP-RIBOSE |
| 4BV3 | A: | CRYSTAL STRUCTURE OF SIRT3 IN COMPLEX WITH THE INHIBITOR EX-527 AND NAD |
| 4BVB | A: | CRYSTAL STRUCTURE OF HUMAN SIRT3 IN COMPLEX WITH THE INHIBITOR EX-527 AND ADP-RIBOSE |
| 4BVH | A:; B:; C: | CRYSTAL STRUCTURE OF HUMAN SIRT3 IN COMPLEX WITH THE INHIBITOR EX-527 AND 2'-O-ACETYL-ADP-RIBOSE |
| 4C7B | A: | COMPLEX OF HUMAN SIRT3 WITH BROMO-RESVERATROL AND FLUOR-DE-LYS PEPTIDE |
| 4IG9 | A:; C:; E:; G: | STRUCTURE OF NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-1 (OPEN STATE, 2.64 A) |
| 4JSR | A: | CRYSTAL STRUCTURE OF HUMAN SIRT3 WITH ELT INHIBITOR 11C [N-{2-[1-(6-CARBAMOYLTHIENO[3,2-D]PYRIMIDIN-4-YL)PIPERIDIN-4-YL]ETHYL}-N'-ETHYLTHIOPHENE-2,5-DICARBOXAMIDE] |
| 4JT8 | A: | CRYSTAL STRUCTURE OF HUMAN SIRT3 WITH ELT INHIBITOR 28 [4-(4-{2-[(2,2-DIMETHYLPROPANOYL)AMINO]ETHYL}PIPERIDIN-1-YL)THIENO[3,2-D]PYRIMIDINE-6-CARBOXAMIDE[ |
| 4JT9 | A: | CRYSTAL STRUCTURE OF HUMAN SIRT3 WITH ELT INHIBITOR 3 [14-(4-{2-[(METHYLSULFONYL)AMINO]ETHYL}PIPERIDIN-1-YL)THIENO[3,2-D]PYRIMIDINE-6-CARBOXAMIDE] |
)
)